Description

Clatinol (clarithromycinum, tinidazolum, lansoprazolum) for oral use №42

Ingredients

Clarinol contains three active ingredients: clarithromycinum, tinidazolum, and lansoprazolum.

Dosage

Clarinol is typically taken orally, as directed by a healthcare professional. The standard dosage is one tablet per day for a specified duration.

Indications

Clarinol is indicated for the treatment of bacterial infections in the respiratory tract, skin, and stomach. It is also used in combination therapy for Helicobacter pylori eradication.

Contraindications

Clarinol is contraindicated in patients with a history of hypersensitivity to any of its components. It should be used with caution in individuals with liver or kidney impairment.

Directions

Clarinol should be taken with food to enhance absorption and reduce the risk of gastrointestinal side effects. It is important to complete the full course of treatment as prescribed.

Scientific Evidence

Studies have shown that the combination of clarithromycinum, tinidazolum, and lansoprazolum in Clarinol exhibits potent antibacterial activity against a wide range of pathogens. The synergistic effects of these components result in enhanced efficacy and reduced development of resistance.

Additional Information

It is essential to inform your healthcare provider about any existing medical conditions or medications before starting Clarinol therapy. Adverse reactions such as nausea, diarrhea, and allergic reactions may occur, and prompt medical attention should be sought if any severe side effects manifest.

Clarinol acts by inhibiting bacterial protein synthesis, DNA replication, and acid secretion in the stomach, leading to the eradication of infections and relief of associated symptoms.

Comparative studies have demonstrated the efficacy of Clarinol in achieving higher eradication rates of Helicobacter pylori compared to standard triple therapy regimens.